Lovastatin Tablet
Product Images NDC 55289-692

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 55289-692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

55289692 Label (55289692)

Lovastatin USP 40 mg oral tablets in a package of 90 tablets, labeled by PD-Rx Pharmaceuticals, Inc. The label includes the NDC number 55289-692-90 and information on reorder number, lot, and expiration date (01/2050). It features a green warning strip for prescription use and instructions to see the package insert for dosage and storage details.*

FDA Label Image

65abb8c3 847f 4fb3 B8de 21888c01210b 01

Chemical structure diagram of lovastatin, showing the molecular arrangement including hydroxyl, ketone, and methyl groups as components of the compound.*

FDA Label Image

65abb8c3 847f 4fb3 B8de 21888c01210b 02

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over years of follow-up. Two lines represent Lovastatin and Placebo groups, with the Placebo line declining more steeply. The graph notes a 37% risk reduction (p < 0.001) favoring Lovastatin over approximately six years.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.